McKesson | MCK - Sales Revenues

Stock Price
835.30
Daily Change
6.98 0.84%
Monthly
-2.89%
Yearly
18.10%
Q2 Forecast
810.39

McKesson reported $106.16B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Acadia Healthcare USD 821.5M 30.1M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Centene USD 49.94B 210M Mar/2026
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cigna USD 72.47B 2.77B Dec/2025
Community Health Systems USD 3.11B 19M Dec/2025
Computer Programs Systems USD 87.79M 3.96M Dec/2025
CVS Health USD 105.7B 2.8B Dec/2025
DaVita Healthcare Partners USD 3.62B 200M Dec/2025
Dentsply International USD 961M 57M Dec/2025
eHealth USD 58.41M 7.45M Sep/2024
Elevance Health USD 49.5B 200M Mar/2026
Encompass Health USD 1.54B 60M Dec/2025
HCA USD 19.11B 400M Mar/2026
Henry Schein USD 3.4B 60M Dec/2025
Humana USD 32.52B 130M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.1B 500M Mar/2026
Laboratory Of America USD 3.52B 40M Dec/2025
McKesson USD 106.16B 3.01B Dec/2025
Molina Healthcare USD 10.8B 580M Mar/2026
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Stryker USD 7.2B 1.14B Dec/2025
Tenet Healthcare USD 5.53B 240M Dec/2025
UnitedHealth USD 111.7B 1.5B Mar/2026
Universal Health Services USD 4.49B 0 Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022